Greiner Michael 4
4 · AVANOS MEDICAL, INC. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Greiner Michael
Interim CEO
Transactions
- Exercise/Conversion
Common Stock
2025-03-04+12,149→ 214,235 total - Tax Payment
Common Stock
2025-03-04$15.13/sh−6,048$91,506→ 208,187 total - Tax Payment
Common Stock
2025-03-04$15.13/sh−4,642$70,233→ 203,545 total
Footnotes (4)
- [F1]Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each PRSU is the economic eqiuvalent of one share of Common Stock.
- [F2]Total beneficially owned includes 666 shares acquired on December 31, 2024 and 522 shares acquired on June 30, 2024 under the Issuer's Employee Stock Purchase Plan.
- [F3]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 12,149 PRSUs which vested on March 4, 2025.
- [F4]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 10,396 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each TRSU is the economic equivalent of one share of Common Stock.